V ClinBio

Chennai, India Founded: 2013 • Age: 13 yrs
V ClinBio provides drug discovery and development services for small and large molecules.
Annual revenue $3,178 Latest available
Total funding - Funding intelligence
Employees 1 Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About V ClinBio

V ClinBio is a company based in Chennai (India) founded in 2013 by Subbu Apparsundaram. It operates as a B2B. The company has 1 employees as of March 31, 2021. V ClinBio operates in a competitive market with competitors including Metabolon, Maze Therapeutics, Alector, Seer and Tango Therapeutics, among others.

  • Headquarter Chennai, India
  • Employees 1 as on 31 Mar, 2021
  • Founders Subbu Apparsundaram
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name V Clinbio Labs Private Limited
  • Date of Incorporation 05 Sep, 2013
  • Jurisdiction Chennai, Tamil Nadu, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $3.18 K (USD)
    0
    as on Mar 31, 2021
  • Net Profit
    -$20.81 K (USD)
    54.73
    as on Mar 31, 2021
  • EBITDA
    -$18.47 K (USD)
    59.81
    as on Mar 31, 2021
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    1

    as on Mar 31, 2021

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of V ClinBio

Premium access

Detailed funding history for V ClinBio

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by V ClinBio

Investments
Premium access

Investment portfolio details for V ClinBio

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - V ClinBio

Premium access

Detailed financials for V ClinBio

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

V Clinbio Comparisons

V ClinBio Primary company
Description
V ClinBio provides drug discovery and development services f...
Location
Chennai, India
Founded Year
2013
Annual Revenue
$3.18 K (USD)
Net Profit
-$20.81 K (USD)
EBITDA
-$18.47 K (USD)
Employees
1
As of 2021
Premium access

Peer comparison for V ClinBio

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of V ClinBio

V ClinBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Metabolon, Maze Therapeutics, Alector, Seer and Tango Therapeutics, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Solutions for biomarker discovery and diagnostic testing are provided.
Locked Locked Locked
Genetic biomarkers are developed for neurological, metabolic, and renal diseases.
Locked Locked Locked
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed.
Locked Locked Locked
Proteomics platform developed for early cancer and neurological disease detection.
Locked Locked Locked
Novel cancer drugs are developed using synthetic lethality screening.
Locked Locked Locked
NeoPhore is focused on cancer neoantigen evolution therapies.
Premium access

Detailed competitors of V ClinBio

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on V Clinbio

Premium access

Complete news archive for V ClinBio

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about V ClinBio

V ClinBio was founded in 2013.

V ClinBio is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.

Subbu Apparsundaram is the current CEO of V ClinBio. They have also founded this company.

As of Mar 31, 2021, the latest employee count at V ClinBio is 1.

Annual revenue of V ClinBio is $3.18K as on Mar 31, 2021.

V ClinBio, established in 2013, excels in providing healthcare solutions, producing pharmaceutical products, drug development, and discovery services. V ClinBio provides drug discovery and development services for small and large molecules. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.

V ClinBio's top competitors include Alector, Lexicon Pharmaceuticals and Maze Therapeutics.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available